Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01955044 · ClinicalTrials.gov registry record · NA
PUFA Supplementation in Premature Infants
A NA study, sponsored by Endeavor Health.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01955044 is a NA study that has completed, run by Endeavor Health. The registered enrollment target is 30 participants.
The verdict
NCT01955044, a NA study, has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if buccal administration of a concentrated formulation of long-chain polyunsaturated fatty acids (LCPUFA) can help to maintain docosahexaenoic acid (DHA) levels in extremely low birth weight (ELBW) infants.
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT LCPUFA supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01955044
The ClinicalTrials.gov registry entry for NCT01955044 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01955044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01955044 about?
NCT01955044 is a clinical study titled "PUFA Supplementation in Premature Infants". The purpose of this study is to determine if buccal administration of a concentrated formulation of long-chain polyunsaturated fatty acids (LCPUFA) can help to maintain docosahexaenoic acid (DHA) levels in extremely low birth weight (ELBW) infants.
What is the current status of trial NCT01955044?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-09. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01955044?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), LCPUFA supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01955044?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.